Skip to the page

Data / Form D filings / Formulate Labs, Inc.

Formulate Labs, Inc.: Form D filings

Formulate Labs, Inc., a company in Fenton, MO, filed 2 Form D notices with the SEC between 2020 and 2025. The latest, on July 10, 2025, reports $1.4 million sold of a $6.9 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1645 Headland Dr., Fenton, MO, 63026
Phone
(312) 283-4854
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1827318

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 10, 2025New notice$6,890,983$1,393,516$5,497,46721Jun 27, 2025sec.gov
Oct 7, 2020New notice$2,500,000$1,443,600$1,056,4007Sep 22, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Osmaan ShahExecutive Officer, Director
Michael SavinoDirector

Other companies in Missouri that filed recently

Every Form D from the week of Jul 7, 2025 · All recent filings in Missouri · All recent Other filings

Read from SEC EDGAR. Amount sold is what Formulate Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.